Article Versions Notes

Nam Y, Choi C-M, Park YS, Jung H, Hwang HS, Lee JC, Lee JW, Lee JE, Kang JH, Jung BH, et al. CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer. Journal of Clinical Medicine. 2022; 11(2):341. https://doi.org/10.3390/jcm11020341

Nam, Yunha, Chang-Min Choi, Young Soo Park, HyunA Jung, Hee Sang Hwang, Jae Cheol Lee, Jung Wook Lee, Jung Eun Lee, Jung Hee Kang, Byung Hun Jung, and et al. 2022. "CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer" Journal of Clinical Medicine 11, no. 2: 341. https://doi.org/10.3390/jcm11020341

Nam, Y., Choi, C. -M., Park, Y. S., Jung, H., Hwang, H. S., Lee, J. C., Lee, J. W., Lee, J. E., Kang, J. H., Jung, B. H., & Ji, W. (2022). CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer. Journal of Clinical Medicine, 11(2), 341. https://doi.org/10.3390/jcm11020341